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Abstract 
Growth hormone induced the accumulation of the stat91 and p84 subunits of the transcription factor complex ISGF3 in nuclear fractions of 
3T3-F442A cells. Nuclear levels of p84 and stat91 peaked 30-60 min after addition of growth hormone. Growth hormone also induced the tyrosine 
phosphorylation of two proteins, with similar sixes to stat91 and ~84, in both nuclear and cytosolic fractions. The time course of growth hormone- 
induced tyrosine phosphorylation of these proteins paralleled the nuclear accumulation of stat91 and ~84. Immunoprecipitation with stat91-specific 
antibodies confirmed that growth hormone induced the tyrosine phosphorylation of stat91 and an associated protein of M, = 120 kDa. These findings 
suggest a mechanism for the modulation of specific gene transcription by growth hormone. 
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1. Introduction 
The effects of pituitary growth hormone (GH) on tis- 
sue growth, metabolism and development are well docu- 
mented [1,2]. Only recently, however, significant details 
have emerged concerning the molecular basis of these 
actions. The GH receptor is a member of the cytokine 
superfamily of receptors [3] which, though devoid of 
intrinsic tyrosine kinase activity, promote rapid changes 
in intracellular protein tyrosine phosphorylation [4-73. 
Carter-Su and colleagues were first to demonstrate tyro- 
sine phosphorylation of the GH receptor in response to 
GH [8] and, more recently, showed that the receptor 
associates with JAK2 [9], a member of the Janus family 
of tyrosine kinases [lo]. Apart from the GH receptor, the 
substrates for JAK2 are not known and it is not clear if 
JAK2 is involved in transmitting all or only a subset of 
GH signals. 
In common with most hormones, growth factors and 
cytokines, GH activates the signalling cascade involving 
mitogen-activated protein (MAP) kinase and ~90~~ [l l- 
141. Since both of these enzymes translocate to the nu- 
cleus and phosphorylate various transcription factors 
[15], this cascade is potential mechanism for the modula- 
tion of gene transcription by GH. Recently, a second, 
more direct, mechanism for signalling to the nucleus has 
been elucidated. Originally described for interferon a//3 
[ 16-181, this involves the multimeric transcription factor 
ISGF3. Upon cell stimulation components of the com- 
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plex become tyrosine phosphorylated in the cytosol be- 
fore translocating to the nucleus where they interact with 
the response lements for specific target genes. It appears 
that one component of ISGF3, a 91-kDa protein known 
as stat91, is a common target for many other cytokines 
and growth factors, including interferon-y [ 19-221, inter- 
let&in-6 [21,23], interleukin- 10 [ 191, epidermal growth 
factor [20,21,24,25] and platelet-derived growth factor 
[25]. Stat91 can combine with other proteins in the nu- 
cleus and this governs its DNA binding specificity [26]. 
Previously we reported [13] that multiple proteins un- 
dergo rapid tyrosine phosphorylation in response to GH 
in 3T3-F442A preadipocytes. In the present study we 
have investigated whether stat91 undergoes increased ty- 
rosine phosphorylation and nuclear translocation in re- 
sponse to GH. 
2. Materials and methods 
2.1. Materials 
Protein A-Sepharose was obtained from Pierce, Chester, UK. Poly- 
clonal antibodies to phosphotyrosine were obtained from ICN. A poly- 
clonal antibody to stat91 was a generous gift from Dr Andrew Larner 
(NIH, MD, USA). A monoclonal antibody, anti-p84/stat91, which 
recognises both the 84-kDa and 91-kDa (stat91) components of ISGF3 
was obtained from Affiniti Research, Nottingham, UK. All other 
chemicals were obtained from Sigma. 
2.2. Cell culture, treatment and preparation of subcellular f actions 
3T3-F442A cells (provided by Dr. Howard Green, Harvard Medical 
School) were cultured and treated with 25 nM human pituitary GH 
(obtained from NIADDK, Bethesda, USA) as described previously 
[13]. Nuclear fractions were prepared using a modification of the 
method described by Sadowski and Gilman [271. Cells from twenty lOO- 
mm plates were suspended in 2.5 ml of Buffer A (20 mM HEPES pH 
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7.9,20 mM Na fluoride, 1 mM Na pyrophosphate, 1mM EDTA, 1 mM 
EGTA, 1 mM Na orthovanadate, 1mM dithiothreitol, 0.2 mM phen- 
ylmethylsulphonyl f uoride, leupeptin (2 &ml), aprotinin (2 &ml) 
and pepstatin A (2 pg/ml)) containing 0.1% NP40. The cells were al- 
lowed to swell on ice for 10 mitt and were then broken by passage 
through a 26G needle. The lysate was centrifuged at 1500 rpm for 4 min 
in a microfuge yielding a nuclei-enrichted pellet and a post-nuclear 
supematant. The pellet was resuspended in Buffer A (without NP40) 
and re-centrifuged. The resulting nuclear pellet was resuspended in250 
~1 of Buffer B (Buffer A containing 20% glycerol and 420 mM NaCl) 
and incubated on ice with occasional agitation for 60 min. The suspen- 
sion was then centrifuged at 14,000 rpm for 20 min in a microfuge and 
the resulting supcmatant aken as the nuclear extract. Cytosolic ex- 
tracts were prepared by centrifugation of the post-nuclear supematant 
at lOOOxg,, for 10 mitt followed by centrifugation of the resulting 
supematant at 200,000 x g_ for 30 min. 
2.3. Immunoprecipitation 
Cells from-ten 100 mm plates were scraped into 1 ml of i.p. lysis buffer 
(25 mM HEPES nH 7.4. 50 mM NaCl. 5 mM EDTA. 30 mM Na 
pyrophosphate, 56 mM Na fluoride, 1 mM Na orthovanadate, 10% 
glycerol, 1% Triton X-100 andprotease inhibitors as above) and rotated 
at 4’C for 20 min. The lysates were claritied by centrifugation at 14,000 
rpm in a microfuge. For immunoprecipitation of stat91, equal quanti- 
ties of protein from control or GH-treated cells were incubated with 
anti-stat91 (1:lOO dilution) for 3 hand precipitates collected by incuba- 
tion for 1 h with protein A-Sepharose. Immunoprecipitates were 
washed three times with i.p. lysis buffer and once with Tris-butfered 
saline and finally boiled with SDS sample buffer. Samples were stored 
at -2O’C until use. 
2.4. Western blotting 
Samples were electrophoresed on 8% SDS-PAGE followed by trans- 
fer to nitrocellulose at 125 mA for 16 h. Blots were blocked in a solution 
containing 3% bovine serum albumin and probed with anti-stat91, 
anti-p84/stat91 or anti-phosphotyrosine antibodies. Phosphotyrosine 
blots were developed with [‘r51]protein A (ICN) and stat91 blots with 
the enhanced chemihuninescence system (ECL, Amersham). All data 
presented are representative of experiments done on at least three sep- 
arate occasions. 
3. Results and discussion 
In resting cells stat91 resides predominently in the cy- 
tosol. To act as a transcription factor cytosolic stat91 is 
activated by tyrosine phosphorylation before translo- 
eating to the nucleus [26]. To investigate whether stat91 
is involved in GH signalling, we first examined whether 
GH induced its accumulation in nuclei-enriched frac- 
tions. We used an antibody which specifically recognises 
both stat91 and ~84, which are alternatively spliced 
products of the same gene [28]. Immunoblots revealed 
that stimulation of 3T3-F442A cells with GH increased 
the levels of both stat91 and p84 in nuclear fractions 
(Fig. 1). Maximal accumulation occurred between 30 
and 60 min following addition of GH. In contrast, the 
cytosolic levels of stat91 and p84 were not consistently 
changed by GH treatment (Fig. 1). 
We next examined whether GH could induce the ap- 
pearance of tyrosine phosphorylation proteins in the nu- 
cleus. Phosphotyrosine immunoblots revealed that GH 
promoted tyrosine phosphorylation in nuclei-enriched 
fractions, most notably of a protein with a similar size 
to stat91 (Fig. 2a). A faintly discernible protein (M, = 84 
kDa) exhibited a similar time course of GH-induced ty- 
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Fig. 1. Time course of growth hormone-induced nuclear accumulation 
of ~84 and stat91. Cells were left untreated (time 0) or stimulated with 
25 nM GH for the indicated times. Nuclear extracts were prepared 
according to section 2 and equal quantities (100 pg) of protein im- 
munoblotted with anti-p84/stat91 antibodies. Cytosolic extracts (50 pug 
protein) from untreated or GH-treated (30 min) cells were run in paral- 
lel for comparison. The migratory positions of ~84 and stat91 are 
indicated. 
rosine phosphorylation (Fig. 2a). 91-kDa and 84-kDa 
phosphotyrosyl proteins were also detected in cytosolic 
fractions from GH-treated cells (Fig. 2b). The fact that 
the time course of GH-induced tyrosine phosphorylation 
of the 91- and 84-kDa proteins detected in the nucleus 
closely paralleled the accumulation of stat91 and p84 in 
the same fraction strongly suggests that these phosphoty- 
rosy1 proteins are the ISGF3 subunits stat91 and ~84. 
Further evidence that GH induces the tyrosine phos- 
phorylation of stat9 1 was obtained by immunoprecipita- 
tion with a polyclonal antibody specific for stat91 fol- 
lowed by phosphotyrosine immunoblotting. Fig. 3 shows 
that a phosphotyrosyl-protein with an apparent molecu- 
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Fig. 2. Time course of growth hormone-induced protein tyrosine phos- 
phorylation in nuclear fractions. Cells were left untreated (time 0) or 
treated with 25 nM GH for the indicated times. Nuclear extracts (panel 
A) or cytosolic extracts (panel B) were prepared according to section 
2 and 100 pg of protein immunoblotted with anti-phosphotyrosine 
antibodies. The migratory positions of molecular mass markers are 
shown to the left. The 91-kDa protein exhibiting increased tyrosine 
phosphorylation in response to GH is arrowed. 
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Fig. 3. Growth hormone induces the tyrosine phosphorylation of 
stat91. Right panel: lysates from control (-) or GH-treated (+) cells 
were immunoprecipitated with anti-stat91 antibody and probed for 
phosphotyrosine as described in section 2. The positions of two proteins 
exhibiting an increase in tyrosine phosphorylation in response to GH 
are indicated by an asterisks. Left panel: Parallel anti-stat91 im- 
munoprecipitates immunoblotted with stat91 antibodies. 
lar mass of 91 kDa was detected in anti-stat91 im- 
munoprecipitates from GH-treated but not control cells. 
Immtmoblotting of parallel immunoprecipitates with 
stat91 antibodies confirmed the migratory position of 
stat91 and that similar quantities of stat91 were present 
in each sample (Fig. 3). Qualitatively similar results were 
obtained using the stat9Up84 monoclonal antibody for 
immunoprecipitation (data not shown). However we 
were unable to detect GH-induced tyrosine phosphoryla- 
tion of p84 in these experiments. This may be a sensitiv- 
ity problem since this antibody detects much lower levels 
of p84 compared to stat91 on immunoblots of 3T3- 
F442A cell lysates (data not shown). Furthermore the 
data in Fig. 2 indicates that the GH-induced tyrosyl 
phosphorylation of p84 is less than that of stat91. 
Interestingly, a second phosphotyrosyl-protein (M, = 
120-130 kDa) was consistently detected in both anti- 
stat91 (Fig. 3) and stat9Up84 immunoprecipitates (data 
not shown), suggesting that, at least in GH-treated cells, 
this protein is tightly associated with stat91. Because of 
its size, it is tempting to speculate that this protein is 
either the GH receptor or JAK2, both of which undergo 
GH-stimulated tyrosine phosphorylation [9]. This possi- 
bility is at present under investigation. 
In conclusion we have shown that GH induced the 
tyrosine phosphorylation and nuclear accumulation of 
the transcription factor stat91. In addition, we observed 
GH-induced nuclear accumulation of p84 and tyrosine 
phosphorylation of a similar sized protein, suggesting 
that GH may target other components of ISGF3. Varia- 
tions in the tyrosine phosphorylation and assembly of 
ISGF3 subunits in response to different cell stimuli have 
been proposed to confer specificity by directing interac- 
tion with different DNA response elements [26]. Al- 
though the precise details of this will require further 
study, our data describe a further mechanism for the 
regulation of specific gene transcription by GH. 
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